Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SMJ.0b013e3181f61528 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A two-month-old developmentally normal full-term female presented with severe feeding intolerance, progressive weight loss, and persistent fussiness, leading to multiple emergency department visits and eventual hospitalization. Initial evaluations, including laboratory tests and imaging, were unremarkable, prompting a series of diagnostic and therapeutic interventions. A multidisciplinary approach, including empiric gastroesophageal reflux disease (GERD) therapy, was started.
View Article and Find Full Text PDFBreeding bird sensitivity to urban habitat quality is multi-scale and strongly dependent on migratory behavior.
Ecol Appl
January 2025
Division of Natural Resources, Park Operations Department, Cleveland Metroparks, Cleveland, Ohio, USA.
Human-caused conversion of natural habitat areas to developed land cover represents a major driver of habitat loss and fragmentation, leading to reorganization of biological communities. Although protected areas and urban greenspaces can preserve natural systems in fragmented landscapes, their efficacy has been stymied by the complexity and scale-dependency underlying biological communities. While migratory bird communities are easy to-study and particularly responsive to anthropogenic habitat alterations, prior studies have documented substantial variation in habitat sensitivity across species and migratory groups.
View Article and Find Full Text PDFIntratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial.
JAMA Oncol
January 2025
Department of Surgery, University of California, San Francisco.
Importance: Intratumoral immunotherapy that leverages the biological characteristics of high-risk ductal carcinoma in situ (DCIS) may be able to reduce the extent of surgical treatment and provide an alternative approach to improve patient outcomes.
Objective: To determine if combination intratumoral immunotherapy can activate immune cells to shrink or eliminate high-risk DCIS.
Design, Setting, And Participants: This phase 1 open-label nonrandomized clinical trial at a single academic center tested the safety and efficacy of intratumoral immunotherapy in patients with high-risk DCIS, defined as at least 2 of the following present: younger than 45 years, tumor size greater than 5 cm, high-grade, palpable mass, hormone receptor (HR)-negative, or ERBB2-positive.
Percutaneous Cryoablation Therapy for Abdominal wall Endometriosis: a Systematic Review and Meta-analysis.
Br J Radiol
January 2025
Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School-University of São Paulo, Ribeirão Preto, SP, Brazil.
Purpose: Abdominal wall endometriosis consists of endometrial tissue between the peritoneum and the abdominal wall. The established treatment involves amenorrheic drugs-not always successful and tolerated-or invasive surgery. In this scenario, minimally invasive techniques such as cryoablation are a potential option.
View Article and Find Full Text PDFStudy of the self-degradation performance of a passive direct methanol fuel cell with an Fe-N-C catalyst.
Dalton Trans
January 2025
School of Astronautics, Harbin Institute of Technology, Harbin, China.
Fe-N-C catalysts are considered promising substitutes for Pt-based catalysts at the cathode in direct methanol fuel cells (DMFCs) owing to their great methanol tolerance. However, Fe-N-C-based DMFCs commonly suffer from a decreased performance under extremely high methanol concentrations and exhibit poor stability, while the underlying mechanism remains controversial. In this study, a self-degradation phenomenon in a passive Fe-N-C-based DMFC was investigated in detail.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!